Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Beckert

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research|January 8, 2015
The Prognostic Role of Optimal Cytoreduction in Advanced, Bowel Infiltrating Ovarian CancerRobert Bachmann, Ralf Rothmund, Bernhard Krämer, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|August 28, 2010
Circadian expression of clock- and tumor suppressor genes in human oral mucosaDerek Zieker, Isabel Jenne, Ingmar Koenigsrainer, et al.
Annals of Surgical Oncology|February 5, 2017
Pharmacodynamics of Oxaliplatin-Derived Platinum Compounds During Hyperthermic Intraperitoneal Chemotherapy (HIPEC): An Emerging Aspect Supporting the Rational Design of Treatment ProtocolsMarkus W Löffler, Heiko Schuster, Anne Zeck, et al.
Annals of Surgical Oncology|March 3, 2009
(18)F-FDG-PET/CT to select patients with peritoneal carcinomatosis for cytoreductive surgery and hyperthermic intraperitoneal chemotherapyChristina Pfannenberg, Ingmar Königsrainer, Philip Aschoff, et al.
International Journal of Cancer|August 19, 2009
Phosphoglycerate kinase 1 a promoting enzyme for peritoneal dissemination in gastric cancerDerek Zieker, Ingmar Königsrainer, Isabel Tritschler, et al.
Cancers|March 10, 2022
Prolonged Exposure to Oxaliplatin during HIPEC Improves Effectiveness in a Preclinical Micrometastasis ModelNick Seyfried, Can Yurttas, Markus Burkard, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|June 23, 2019
Peritoneal metastasis in gastric cancer: results from the German databaseBeate Rau, Andreas Brandl, Pompiliu Piso, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|August 28, 2010
Phosphoglycerate kinase 1 promoting tumor progression and metastasis in gastric cancer - detected in a tumor mouse model using positron emission tomography/magnetic resonance imagingDerek Zieker, Ingmar Königsrainer, Jürgen Weinreich, et al.
Cancer Research|May 24, 2018
Mapping the HLA Ligandome of Colorectal Cancer Reveals an Imprint of Malignant Cell TransformationMarkus W Löffler, Daniel J Kowalewski, Linus Backert, et al.
BMC Medical Genetics|August 17, 2018
First case report of malignant peritoneal mesothelioma and oral verrucous carcinoma in a patient with a germline PTEN mutation: a combination of extremely rare diseases with probable further implicationsMarkus W Löffler, Julia Steinhilber, Franz J Hilke, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research|January 8, 2015
The Prognostic Role of Optimal Cytoreduction in Advanced, Bowel Infiltrating Ovarian CancerRobert Bachmann, Ralf Rothmund, Bernhard Krämer, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|August 28, 2010
Circadian expression of clock- and tumor suppressor genes in human oral mucosaDerek Zieker, Isabel Jenne, Ingmar Koenigsrainer, et al.
Annals of Surgical Oncology|February 5, 2017
Pharmacodynamics of Oxaliplatin-Derived Platinum Compounds During Hyperthermic Intraperitoneal Chemotherapy (HIPEC): An Emerging Aspect Supporting the Rational Design of Treatment ProtocolsMarkus W Löffler, Heiko Schuster, Anne Zeck, et al.
Annals of Surgical Oncology|March 3, 2009
(18)F-FDG-PET/CT to select patients with peritoneal carcinomatosis for cytoreductive surgery and hyperthermic intraperitoneal chemotherapyChristina Pfannenberg, Ingmar Königsrainer, Philip Aschoff, et al.
International Journal of Cancer|August 19, 2009
Phosphoglycerate kinase 1 a promoting enzyme for peritoneal dissemination in gastric cancerDerek Zieker, Ingmar Königsrainer, Isabel Tritschler, et al.
Cancers|March 10, 2022
Prolonged Exposure to Oxaliplatin during HIPEC Improves Effectiveness in a Preclinical Micrometastasis ModelNick Seyfried, Can Yurttas, Markus Burkard, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|June 23, 2019
Peritoneal metastasis in gastric cancer: results from the German databaseBeate Rau, Andreas Brandl, Pompiliu Piso, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|August 28, 2010
Phosphoglycerate kinase 1 promoting tumor progression and metastasis in gastric cancer - detected in a tumor mouse model using positron emission tomography/magnetic resonance imagingDerek Zieker, Ingmar Königsrainer, Jürgen Weinreich, et al.
Cancer Research|May 24, 2018
Mapping the HLA Ligandome of Colorectal Cancer Reveals an Imprint of Malignant Cell TransformationMarkus W Löffler, Daniel J Kowalewski, Linus Backert, et al.
BMC Medical Genetics|August 17, 2018
First case report of malignant peritoneal mesothelioma and oral verrucous carcinoma in a patient with a germline PTEN mutation: a combination of extremely rare diseases with probable further implicationsMarkus W Löffler, Julia Steinhilber, Franz J Hilke, et al.
Pageof 7